Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 144A is a soluble, cytoplasmic protein predicted to localize near the nucleus in human cells[2]. It contains a coiled-coil structure and a conserved domain of unknown function (DUF3496), as well as a leucine zipper motif. The protein consists mostly of alpha helices and has low expression across tissues[2][5]. Biological studies highlight a role in *calcium oxalate binding*, with possible involvement in kidney stone formation and prevention via inhibition of crystal adhesion and related cell injury[1][4]. Genetic association studies link CCDC144A to nephrolithiasis and possibly autism spectrum disorder. Though not a classic therapeutic target, its anti-lithiatic activity suggests potential relevance for kidney stone research, but no drugs or mechanisms have been validated. Despite shared nomenclature with other CCDC144 family proteins and a pseudogene (CCDC144NL), CCDC144A is a distinct, protein-coding gene, not a pseudogene[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 144A (CCDC144A).